Cancer Genomics Consortium
The cancer genomics consortium (cgc) is committed to providing high quality education and promoting best laboratory practices in clinical cancer genomics.
GiveRadar doesn't take a cut. Donate directly on their site.
Make your donationAbout Cancer Genomics Consortium
The Cancer Genomics Consortium (CGC) represents a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics.
Verified certifications
Confirmed against the issuing authority - not self-reported.
Mission
The cancer genomics consortium (cgc) is committed to providing high quality education and promoting best laboratory practices in clinical cancer genomics.
Focus areas & reach
· What they work on and whereHow it stacks up against peers
· vs. 8 similar health in United StatesConcerns
· None foundWhere every $1 goes
· FY2023 · IRS 990 (FY2023)GiveRadar Analysis
Original analysis from GiveRadar's dataset of comparable organizations
From what GiveRadar has verified so far, Cancer Genomics Consortium has a complete profile, cross-referenced across 3 independent sources including the IRS.
- It has more complete contact information than nearly all comparable charities, with a verified website, email, phone and address on record. See national comparisons
- It has more complete governance disclosure than nearly all comparable charities, because GiveRadar has verified leadership, executive compensation, a mission statement and a founding date. See national comparisons
- GiveRadar's profile for Cancer Genomics Consortium draws on its financial disclosures and its registration, in line with the typical health charities in the United States it tracks. View this cohort
- government registration
- financial records (5 filed years)
- disclosed leadership
- a website
- a contact email
- a donation page
- an owner-submitted profile claim
Analysis based on GiveRadar's benchmark dataset of 2026-07-03. It describes what GiveRadar has verified, not a judgment of the organization itself.
Common questions
· Auto-generated from filings + methodologyCancer Genomics Consortium is a registered health nonprofit based in Rochester, MN, United States. It is registered with the Internal Revenue Service (IRS). It was founded in 2010 and has been operating for 16 years. Its EIN is 273232063. According to GiveRadar's records, it holds active tax-deductible status on the IRS Publication 78 list, which means donations are tax-deductible and the organization is in good standing with the IRS. GiveRadar's Integrity Assessment for the organization is 71/100, which reflects how much public information is available, not whether the charity is legitimate. The organization reports $441K in annual revenue. 71 officers and directors are publicly disclosed. No red flags have been detected.
Cancer Genomics Consortium's EIN (Employer Identification Number) is 273232063. This is the organization's IRS tax identification number; you can use it to verify tax-exempt status and to look up its Form 990 filings with the IRS.
Cancer Genomics Consortium has a GiveRadar Integrity Assessment of 71/100. This score combines five components: Registration (20 pts), Financial Transparency (30 pts), Governance (20 pts), Contact Availability (10 pts), and Data Recency (20 pts), with negative adjustments for any red flags. A score of 71 ('Strong transparency') reflects well-documented governance, recent financials, named leadership, and working contact details. The charity allocates 85% of expenses to programs, which contributes positively to its score. For comparison, the average integrity assessment for health charities in United States is 90/100.
Cancer Genomics Consortium is located in Rochester, MN, United States. The organization was established in 2010 and has been active for 16 years.
Based on official tax filings, Cancer Genomics Consortium has $441K in annual revenue. It allocates 85% of expenses to programs and services. This is in line with the average of 89% for health charities in United States. Its revenue is below the peer average of $41M. Create a free GiveRadar account to view the complete financial breakdown with year-over-year trends.
Cancer Genomics Consortium is classified as a Health organization, registered in United States. It operates as a Supporting organization (509(a)(3)). By size, it is categorized as a small organization. It has $441K in annual revenue. The organization has 71 disclosed officers and directors.
No red flags have been detected for Cancer Genomics Consortium. GiveRadar automatically screens charities for concerning patterns including high executive compensation, low program spending, and missing financial filings. Based on available official data, no issues have been identified.
According to GiveRadar's records, Cancer Genomics Consortium holds active tax-deductible status on the IRS Publication 78 list, which means donations are tax-deductible and the organization is in good standing with the IRS. It is registered with the Internal Revenue Service (IRS). It reports that 85% of expenses go to programs (the peer average is 89%). You can donate directly through their official donation page linked on their GiveRadar profile. GiveRadar provides data for research and does not endorse any organization. A GiveRadar Integrity Assessment reflects how much public data is available, not whether an organization is safe to donate to, so it is always smart to do your own research before giving.
The Cancer Genomics Consortium (CGC) represents a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Cancer Genomics Consortium is classified as a health organization registered in United States. The organization was founded in 2010.
Among health charities registered in United States: It allocates 85% of expenses to programs, in line with the peer average of 89%. Its annual revenue of $441K is below the peer average of $41M.
Yes, donations to Cancer Genomics Consortium are generally tax-deductible in the United States. Cancer Genomics Consortium is a 501(c)(3) tax-exempt organization. Its EIN is 273232063, which you can use for tax filing purposes. Donors can typically deduct contributions on their federal income tax return if they itemize deductions. Consult a tax professional for guidance specific to your situation.
Filing history
5 years on file from IRS 990 (FY2023): revenue, expenses, program spending, assets, and liabilities by fiscal year.
See 5 years of revenue, expense breakdowns, and balance sheet.
Sign up to viewTaxes
Tax-deductibility for donors
Donations may be tax-deductible for residents of United States under local rules. Confirm with the charity directly.
CANCER GENOMICS CONSORTIUM is registered in United States. Donations from the Netherlands to charities outside the EU/EEA are generally not tax-deductible for Dutch donors unless the charity is listed on the Dutch ANBI register with foreign-recognized status.
Always confirm tax treatment with the charity directly or your tax advisor before donating.
Leadership
From FY2023 filing
Officers & trustees (25)
Source: Public filings
25 officers and trustees on file - free with a GiveRadar account.
Latest news
From global news sources
No recent news coverage found
News coverage will appear here when articles mention this organization.
Activity timeline
Filings and press mentions, merged
No reviews yet. Be the first to share your experience.
Have you donated or volunteered here?
Share your experience - it takes 30 seconds. Verified reviews help other donors decide.
Sign up to write a reviewCause areas in United States
How many charities work in each area, with this charity's area highlighted.
Most common causes in United States
Causes charities work on most.
Sources and verification
- Registration and legal identity
- Internal Revenue Service (IRS) - Tax Exempt Organization Search
- Financial filings
- IRS Form 990 filings - Fiscal year 2023 most recent on file.
- Officers and trustees
- Internal Revenue Service (IRS) - Tax Exempt Organization Search - 71 disclosed in the public registry.
- Supplementary verification
- Charity Navigator
Data freshness
What we know and don't know
Exactly which public data we hold on this charity. Our score reflects transparency, not impact.
-
Financial data · FY2023 on record
-
Named leadership · 71 officers on file
-
Government registration · Registered with an official registry
-
Mission statement · Published
-
Official website · On record
-
Headquarters address · On file
-
Direct contact · Email or phone published
-
Tax-deductibility · Verified
-
Founding date · 2010
-
Executive payTop-officer pay not disclosed
-
Programs & activitiesNo named programs listed by the charity
Methodology
GiveRadar builds each profile primarily from official government charity registries, supplemented where available by third-party nonprofit databases and news archives, and combines it into a single 0-100 integrity assessment. The exact sources for this charity are listed above. We don't take a cut of any donation, ever.
Read full methodologyAre you the owner or a board member?
If you represent this organization and want to correct or update its data, you can claim this listing to edit details yourself, or email [email protected] with the correct information. We review every request and respond within 30 days.
Report an issue
Tell us what's wrong with this charity's page. We review every report and typically reply within 2 business days.
Report sent
Thanks for flagging this. Our team will review it.
Press Esc to close
Save Cancer Genomics Consortium?
Create a free GiveRadar account to save charities and track them in your dashboard.
Quick facts about Cancer Genomics Consortium
- What is Cancer Genomics Consortium?
- Cancer Genomics Consortium is a health supporting organization (509(a)(3)) based in Rochester, United States. The Cancer Genomics Consortium (CGC) represents a group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics.
- When was Cancer Genomics Consortium founded?
- Cancer Genomics Consortium was founded in 2010.
- Who leads Cancer Genomics Consortium?
- Rashmi Kanagal-Shamanna MD serves as President.
- Where is Cancer Genomics Consortium located?
- Headquartered in Rochester, MN, United States.
- What is Cancer Genomics Consortium's annual budget?
- Annual revenue for fiscal year 2023 is approximately $100K-$1M. 85% of expenses go to program services.
- Is Cancer Genomics Consortium trustworthy?
- Cancer Genomics Consortium has a GiveRadar Integrity Assessment of 71 out of 100 (Strong transparency). The score reflects public-data transparency: registration, financial disclosure, governance, contact details, and how recently data was refreshed. It does not measure program impact.
- What is Cancer Genomics Consortium's registration number?
- IRS EIN: 273232063.
- What is Cancer Genomics Consortium's website?
- http://www.cancergenomics.org